CVS Health Hold Rating Justified by Guidance Reduction and Uncertain Cost Trends

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on CVS Health (CVS – Research Report), retaining the price target of $76.00. ...

Related Keywords

Steve Baxter ,Wells Fargo ,Barclays ,Analyst Steve Baxter ,Research Report ,Medicare Advantage ,Tipranks Premium ,